Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Clinical trial NCT00849290 · COMPLETED

Trial details

NCT number: NCT00849290
Sponsor: Dendreon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Androgen Independent Prostate Cancer

Start date: 2004-04-01
Primary completion: 2009-01-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.